KTTA$0.5028+36.63%
Pasithea Therapeutics Corp.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$16.8M
Float & O/S:
Inst Own:
DilutionScan read 26 of Pasithea Therapeutics Corp.'s SEC filings and found 16 warrant series, 1 ATM program, 2 shelf registrations, 2 S-1 registrations and 1 completed offering on file for KTTA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Sep 28, 2026.